Last update 23 Nov 2024

JY-231

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
JY 231, JY231
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Cell replacements
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesNeoplasms+ [1]
Active Indication
Systemic Lupus ErythematosusRefractory B Acute Lymphoblastic LeukemiaB-Cell Lymphoma
Inactive Indication-
Originator Organization
Guangdong Provincial People's Hospital
Active Organization
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaGuangdong Provincial People's Hospital
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

7
Clinical Trials associated with JY-231
NCT06689917 / Not yet recruitingNot ApplicableIIT
JY231 Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia - a Safety, Tolerability, and Efficacy Study
NCT06675422 / RecruitingPhase 1/2IIT
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) - A Safety, Tolerability, and Efficacy Study
NCT06514768 / RecruitingEarly Phase 1IIT
JY231 Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia(B-ALL ) Early Exploratory Clinical Studies on Safety, Tolerability, and Initial Efficacy
100 Clinical Results associated with JY-231
Login to view more data
100 Translational Medicine associated with JY-231
Login to view more data
100 Patents (Medical) associated with JY-231
Login to view more data
100 Deals associated with JY-231
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Systemic Lupus ErythematosusPhase 2
CN
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
09 Oct 2024
Refractory B Acute Lymphoblastic LeukemiaPhase 1
CN
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
20 Jun 2024
B-Cell LymphomaPhase 1
CN
Guangdong Provincial People's Hospital
18 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free